Yüklüyor......
Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity
PURPOSE: The purpose of this study was to report on the axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for threshold retinopathy of prematurity. METHODS: The authors conducted a comparative, consecutive, original study. RESULTS: Twenty-five ey...
Kaydedildi:
| Yayımlandı: | Clin Ophthalmol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4959583/ https://ncbi.nlm.nih.gov/pubmed/27499611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S110717 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|